Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Ambu A/S: PRICING AND FURTHER DETAILS ON THE OFFERING OF 1,255,000 B SHARES IN AMBU A/S

Ambu A/S
Posted on: 15 Nov 17

The offering (the "Offering") of up to 1,255,000 new B shares in Ambu A/S ("Ambu "or the "Company") has now been completed through an accelerated bookbuilding process. Reference is made to company announcement no. 04 2017/18 of 14 November 2017.


As part of the Offering, Ambu will issue a total of 1,255,000 new B shares at a subscription price of DKK 537 per share, resulting in gross proceeds for Ambu totalling DKK 674 million.

Company announcement no 05_2017_18


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Ambu A/S via GlobeNewswire
HUG#2149884
GlobeNewswire
globenewswire.com

Last updated on: 16/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.